Literature DB >> 9522914

The use of cardiac troponin-I (cTnI) to determine the incidence of myocardial ischemia and injury in patients with aneurysmal and presumed aneurysmal subarachnoid hemorrhage.

M B Horowitz1, D Willet, J Keffer.   

Abstract

A prospective single center study was performed to determine the minimal preoperative incidence of unrecognized cardiac injury in patients suffering aneurysmal and presumed aneurysmal subarachnoid hemorrhage (SAH). When caring for such patients in the pre- and post operative period clinicians must be aware of the possibility of cardiac injury even when a history of previous cardiac symptomatology is not present. Forty-seven consecutive patients suffering from SAH over a five-month period underwent serum measurements of the cardiac muscle marker troponin I (cTnI) immediately upon admission. Repeat studies, if possible, were done 24 hours later. EKG was performed in all patients and was available for review in 44 of the 47 cases. Echocardiography was performed in four of eight patients with elevated cTnI levels. Signs and symptoms relating to cardiac ischemia were recorded by the patients' physicians and nurses. Eight individuals (17%) had elevations in cardiac troponin I levels. Because surgical treatment is generally carried out as soon as possible following the hemorrhage, many patients with normal troponin I levels within twenty-four hours of their hemorrhage were operated upon before a repeat enzyme could be obtained or possibly before elevations could be recorded. In addition, a number of patients were referred to our center several days post-hemorrhage at a time when marker levels may have normalized. Therefore, the 17% incidence of elevated cTnI may be an underestimate. Only two of the eight patients had clinical abnormalities in cardiac function. Four patients with elevated levels had echocardiograms, three of which were abnormal. One additional patient died of a myocardial infarction before an echocardiogram could be obtained. EKG was abnormal in six of the seven patients with elevated troponin who had tracings available for review. Recordings consistent with recent myocardial ischemia were present in four of these. Of the 39 patients with negative troponin I levels, 37 had EKG available for review. None had recordings clearly consistent with recent myocardial ischemia although 13 were suggestive of ischemic changes. None of these 39 patients had pre- or post-operative clinical changes in cardiac function. Elevations in troponin I appeared to be unrelated to the patient's Hunt and Hess grade or Fisher score although our numbers were too small to draw any meaningful conclusions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9522914     DOI: 10.1007/s007010050063

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  29 in total

Review 1.  Extracerebral organ dysfunction in the acute stage after aneurysmal subarachnoid hemorrhage.

Authors:  Wouter J Schuiling; Paul J W Dennesen; Gabriël J E Rinkel
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage.

Authors:  Jonathan G Zaroff; Ludmila Pawlikowska; Jacob C Miss; Sirisha Yarlagadda; Connie Ha; Achal Achrol; Pui-Yan Kwok; Charles E McCulloch; Michael T Lawton; Nerissa Ko; Wade Smith; William L Young
Journal:  Stroke       Date:  2006-05-25       Impact factor: 7.914

3.  Ischemic-appearing electrocardiographic changes predict myocardial injury in patients with intracerebral hemorrhage.

Authors:  Kohei Hasegawa; Megan L Fix; Lauren Wendell; Kristin Schwab; Hakan Ay; Eric E Smith; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein; David F M Brown
Journal:  Am J Emerg Med       Date:  2011-03-29       Impact factor: 2.469

4.  Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage.

Authors:  Alexander Kopelnik; Landis Fisher; Jacob C Miss; Nader Banki; Poyee Tung; Michael T Lawton; Nerissa Ko; Wade S Smith; Barbara Drew; Elyse Foster; Jonathan Zaroff
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

5.  Initial troponin level as a predictor of prognosis in patients with intracerebral hemorrhage.

Authors:  Pil-Wook Chung; Yu Sam Won; Young Joon Kwon; Chun Sik Choi; Byung Moon Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-06-30

6.  Acute myocardial infarction complicating subarachnoid haemorrhage.

Authors:  L B J van der Velden; L C Otterspoor; L J Schultze Kool; G J Biessels; F W A Verheugt
Journal:  Neth Heart J       Date:  2009-08       Impact factor: 2.380

Review 7.  [Elevated troponin and ECG alterations in acute ischemic stroke and subarachnoid hemorrhage].

Authors:  T Liman; M Endres
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

8.  Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage.

Authors:  Marilyn Hravnak; J Michael Frangiskakis; Elizabeth A Crago; Yuefang Chang; Masaki Tanabe; John Gorcsan; Michael B Horowitz
Journal:  Stroke       Date:  2009-08-27       Impact factor: 7.914

9.  Neurogenic Cardiac Injury.

Authors:  Nader M. Banki; Jonathan G. Zaroff
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-12

10.  B-type natriuretic peptide release and left ventricular filling pressure assessed by echocardiographic study after subarachnoid hemorrhage: a prospective study in non-cardiac patients.

Authors:  Eric Meaudre; Christophe Jego; Nadia Kenane; Ambroise Montcriol; Henry Boret; Philippe Goutorbe; Gilbert Habib; Bruno Palmier
Journal:  Crit Care       Date:  2009-05-20       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.